Cargando…

Pre-clinical studies of a novel anti-mitotic agent, amphethinile.

A new antitumour agent is described, which has been shown to induce a G2/M block in murine leukaemia cells in vitro. In addition this agent has been shown to be equally toxic toward parental and daunorubicin-resistant P388 cells in vitro. These resistant cells are highly cross-resistant to the estab...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGown, A. T., Ewen, C., Smith, D. B., Fox, B. W.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1988
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246435/ https://www.ncbi.nlm.nih.gov/pubmed/3358906

Ejemplares similares

Interaction of the novel agent amphethinile with tubulin.
por: McGown, A. T., et al.
Publicado: (1989)

A phase I and pharmacokinetic study of amphethinile.
por: Smith, D. B., et al.
Publicado: (1988)

Comparison of daunorubicin and anthrapyrazolone sensitivity and transport in resistant cell lines.
por: McGown, A., et al.
Publicado: (1987)

Metallothionein levels in ovarian tumours before and after chemotherapy.
por: Murphy, D., et al.
Publicado: (1991)

005 OP: ENTREPRENEURIALISM, ADAPTATION, AND DISCRETION AMONG NURSES IN A TRANSNATIONAL COLLABORATION IN MALAWI AND TANZANIA
por: McGown, M
Publicado: (2017)

Novel heterozygous deletion in the HNF1β gene - adolescent with antibody negative diabetes, longstanding hyperglycaemia without ketosis, cataracts, small echogenic kidneys with a cortical cyst, pancreatic atrophy, exocrine pancreatic insufficiency and a uterine anomaly
por: Conwell, Louise S, et al.
Publicado: (2015)

Sodium Taurocholate Micelles in Fluorometrix Analysis
por: McGown, Linda B., et al.
Publicado: (1988)

Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical features.
por: Renninson, J., et al.
Publicado: (1994)

Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy.
por: Murphy, D., et al.
Publicado: (1992)

The interaction with tubulin of a series of stilbenes based on combretastatin A-4.
por: Woods, J. A., et al.
Publicado: (1995)

SUN-270 Heterozygous Mutation in ABCC8 in a Pedigree with Congenital Hyperinsulinism, Multiple Macrosomic Stillbirths, and Adult-Onset Diabetes Mellitus
por: Ludwig, Karissa, et al.
Publicado: (2019)

Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1.
por: Prendiville, J., et al.
Publicado: (1994)

G-Quadruplex Guanosine Gels and Single Walled Carbon Nanotubes
por: Yu, Yuehua, et al.
Publicado: (2013)

ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosis
por: McGown, Alexander, et al.
Publicado: (2016)

Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcome.
por: Wrigley, E. C., et al.
Publicado: (1996)

Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro
por: Booth, C, et al.
Publicado: (1999)

A phase I study of intravenous bryostatin 1 in patients with advanced cancer.
por: Prendiville, J., et al.
Publicado: (1993)

A custom next generation sequencing panel to identify the cause of monogenic disorders of insulin secretion, disorders of sexual development and noonan syndrome
por: McGown, Ivan, et al.
Publicado: (2015)

P04.30. Physical inactivity among employees at major academic medical center and university
por: Birdee, G, et al.
Publicado: (2012)

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug
por: Grosios, K, et al.
Publicado: (1999)

Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro.
por: McGown, A. T., et al.
Publicado: (1998)

Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma
por: Zhai, Lei, et al.
Publicado: (2023)

Proximal 6q, a region showing allele loss in primary breast cancer.
por: Orphanos, V., et al.
Publicado: (1995)

Depletion of pre-mRNA splicing factor Cdc5L inhibits mitotic progression and triggers mitotic catastrophe
por: Mu, R, et al.
Publicado: (2014)

Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours
por: Cheeseman, S L, et al.
Publicado: (2000)

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
por: Mohr, Lisa, et al.
Publicado: (2017)

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma
por: Blackhall, F H, et al.
Publicado: (2001)

Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li–Fraumeni syndrome
por: Burt, E C, et al.
Publicado: (1999)

Investigating the differential impact of school and community-based integrated control programmes for soil-transmitted helminths in Timor-Leste: the (S)WASH-D for Worms pilot study protocol
por: Clarke, Naomi E., et al.
Publicado: (2016)

A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier.
por: Varley, J. M., et al.
Publicado: (1998)

Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features
por: Shaw, Matthew P., et al.
Publicado: (2018)

Randomized controlled pilot of a group antenatal care model and the sociodemographic factors associated with pregnancy-related empowerment in sub-Saharan Africa
por: Patil, Crystal L., et al.
Publicado: (2017)

Anti-mitotic therapies in cancer
por: Tischer, Julia, et al.
Publicado: (2019)

The Crystal Structure of the Hsp90-LA1011 Complex and the Mechanism by Which LA1011 May Improve the Prognosis of Alzheimer’s Disease
por: Roe, S. Mark, et al.
Publicado: (2023)

A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.
por: Jayson, G. C., et al.
Publicado: (1995)

Pre-clinical evaluation of a novel chloroethylating agent, Clomesone.
por: Matthew, A. M., et al.
Publicado: (1993)

Is the assumption of equal distances between global assessment categories used in borderline regression valid?
por: McGown, Patrick J., et al.
Publicado: (2022)

Pre-clinical evaluation of a novel class of anti-cancer agents, the Pyrrolo-1, 5-benzoxazepines
por: Greene, LM, et al.
Publicado: (2016)

Analogues of Y27632 increase gap junction communication and suppress the formation of transformed NIH3T3 colonies
por: Hampson, L, et al.
Publicado: (2009)

A novel NR5A1 variant in an infant with elevated testosterone from an Australasian cohort of 46,XY patients with disorders of sex development
por: Wu, Joyce Y, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l2k7rcf4e4nriei021i0v4nqv3